| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |